1986
DOI: 10.1016/s0168-8278(86)80125-8
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of chronic delta hepatitis with α-2 recombinant interferon

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
15
0
3

Year Published

1991
1991
2019
2019

Publication Types

Select...
5
3
2

Relationship

0
10

Authors

Journals

citations
Cited by 43 publications
(18 citation statements)
references
References 7 publications
0
15
0
3
Order By: Relevance
“…For hepatitis D patients, interferon has been used for treatment. Unfortunately, the success rate was very low, and post-treatment relapse is common (49,50). How HDV escapes from interferon activity remains unknown.…”
Section: Discussionmentioning
confidence: 99%
“…For hepatitis D patients, interferon has been used for treatment. Unfortunately, the success rate was very low, and post-treatment relapse is common (49,50). How HDV escapes from interferon activity remains unknown.…”
Section: Discussionmentioning
confidence: 99%
“…The HBeAg-positive patients have significantly higher HBsAg levels than HBeAgnegative patients. 26 Although severe HDV occurs in patients who are HBeAg-positive, 27,28 the percentage of liver transplant recipients is higher in HBeAgnegative patients. In our patients, the anti-HBe antibody positive rate was 100%.…”
Section: Discussionmentioning
confidence: 99%
“…HDAg in the liver and serum diminishes or disap pears, HDV RNA in serum disappears and aspartate aminotransferase levels drop. After stopping treatment HDV replication usually reappears with elevation of serum aspartate aminotransferase levels [132,133] …”
Section: Treatment Of Chronic Hepatitis Dmentioning
confidence: 99%